Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK of Accordion Pill Carbidopa-Levodopa vs Sinemet in Parkinson's Disease
NCT03576638Phase 2Unknown
- Sponsor
- Intec Pharma Ltd.
- Start
- Jul 2018
- Primary completion
- Jan 2019
- Modality
- Small Molecules
01
Overview
Phase 2, open-label, single-arm trial of carbidopa + levodopa in Parkinson's disease (PD), sponsored by Intec Pharma Ltd. Primary endpoint: Variability in plasma levodopa concentration at Day 8. Status: unknown.
02
Drugs
carbidopa + levodopa
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT03576638.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03576638.